Platform headspace gas chromatography method for high-throughput determination of residual solvents in pharmaceutical materials

被引:8
作者
Zou, Lanfang [1 ]
Guo, Xun [1 ]
McElderry, John-David [1 ]
机构
[1] Biogen Inc, Analyt Dev, Cambridge, MA 02142 USA
关键词
Residual solvent analysis; Headspace gas chromatography -flame ioniza; tion detection (HSGC-FID); Green analytical chemistry; Pharmaceutical chemistry; Generic method;
D O I
10.1016/j.jpba.2023.115349
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Static headspace capillary gas chromatography (HSGC) has been employed to monitor the level of residual solvents in the pharmaceutical materials. Most of the HSGC methods, however, consume significant amounts of diluents and require considerable amount of sample preparation time. Accordingly, a HSGC method featured with fast turnaround time, and minimal amount of solvent use has been developed for the quantitative analysis of 27 residual solvents frequently used in the development and manufacturing processes of pharmaceutical in-dustry. This HSGC-FID method employs a commercially available fused silica capillary column, a split injection (40:1), and a programmed temperature ramp. It was qualified for specificity, accuracy, repeatability/precision, linearity, LOQ, solution stability, and robustness using two representative sample matrices. The standards, samples and spiked samples were demonstrated to be stable for at least 10 days at room temperature in sealed headspace vials with a recovery of >= 93%. The method was also shown to be robust, and its performance was not affected by small changes of carrier gas flow rate, initial oven temperature or the headspace oven temperature. In this new approach, the analytical sample was prepared by dissolving the sample into 1 mL of the diluent and the standard solution was prepared by diluting 1 mL of the custom-made stock into 9 mL of the diluent whereas the traditional approach requires liters of the diluent, making the new approach environmentally friendly, sus-tainable, economical, agile, error-proofing and thus appropriate for a variety of pharmaceutical applications.
引用
收藏
页数:7
相关论文
共 23 条
[1]   A high thermally stable oligomer-based supramolecular solvent for universal headspace Gas Chromatography: Proof-of-principle determination of residual solvents in drugs [J].
Angel Salatti-Dorado, Jose ;
Gonzalez-Rubio, Soledad ;
Garcia-Gomez, Diego ;
Cardenas, Soledad ;
Rubio, Soledad .
ANALYTICA CHIMICA ACTA, 2019, 1046 :132-139
[2]   Residual solvent testing: A review of gas-chromatographic and alternative techniques [J].
B'Hymer, C .
PHARMACEUTICAL RESEARCH, 2003, 20 (03) :337-344
[3]   Generic gas chromatography flame ionization detection method using hydrogen as the carrier gas for the analysis of solvents in pharmaceuticals [J].
Bernardoni, Frank ;
Halsey, Hoist M. ;
Hartman, Robert ;
Nowak, Timothy ;
Regalado, Erik L. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 165 :366-373
[4]   Analysis of residual solvents by fast gas chromatography [J].
Chen, TK ;
Phillips, JG ;
Durr, W .
JOURNAL OF CHROMATOGRAPHY A, 1998, 811 (1-2) :145-150
[5]   A generic static headspace gas chromatography method for determination of residual solvents in drug substance [J].
Cheng, Chang ;
Liu, Shaorong ;
Mueller, Bradford J. ;
Yan, Zimeng .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (41) :6413-6421
[6]  
Dai L, 2010, LC GC N AM, V28, P54
[7]   Generic gas chromatography-flame ionization detection method for quantitation of volatile amines in pharmaceutical drugs and synthetic intermediates [J].
Graffius, Gabriel C. ;
Jocher, Brandon M. ;
Zewge, Daniel ;
Halsey, Holst M. ;
Lee, Gary ;
Bernardoni, Frank ;
Bu, Xiaodong ;
Hartman, Robert ;
Regalado, Erik L. .
JOURNAL OF CHROMATOGRAPHY A, 2017, 1518 :70-77
[8]   Development of an Automated Headspace Gas Chromatography Instrument for the Determination of Residual Solvents in Pharmaceutical Compounds and Reaction Mixtures [J].
Hamilton, Simon E. ;
Rossington, Marc D. ;
Bertrand, Alexia .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (02) :189-194
[9]  
International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use Q2 (ICH Q2(R2)), VAL AN PROC 5
[10]  
International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use Q3C (ICH Q3C), US